The aim of this study was to evaluate associations of motor and non-motor symptoms with dopamine transporter binding in prodromal stage of synucleinopathies. We examined 74 patients with idiopathic REM sleep behavior disorder (RBD), which is a prodromal synucleinopathy, and 39 controls using Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Montreal Cognitive Assessment, University of Pennsylvania Smell Identification Test (UPSIT), Farnsworth-Munsell 100 hue test, orthostatic test, Scales for Outcomes in PD-Autonomic, Beck depression inventory-II, State-Trait Anxiety Inventory, and video-polysomnography. Electromyographic muscle activity during REM sleep was quantified according to Sleep Innsbruck-Barcelona criteria. In 65 patients, dopamine transporter single-photon emission computed tomography (DAT-SPECT) imaging was performed, putaminal binding ratio was calculated and scans were classified as normal, borderline, or abnormal. Compared to controls, RBD patients had significantly more severe scores in all examined tests. Patients with abnormal DAT-SPECT had higher MDS-UPDRS motor score (p = 0.006) and higher prevalence of orthostatic hypotension (p = 0.008). Putaminal binding ratio was positively associated with UPSIT score (p = 0.03) and negatively associated with tonic (p = 0.003) and phasic (p = 0.01) muscle activity during REM sleep. These associations likely reflect simultaneous advancement of underlying pathology in substantia nigra and susceptible brainstem and olfactory nuclei in prodromal synucleinopathy.

Department of Biomedical Informatics Faculty of Biomedical Engineering Czech Technical University Prague Kladno Czech Republic

Department of Circuit Theory Faculty of Electrical Engineering Czech Technical University Prague Prague Czech Republic

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Institute of Nuclear Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Zobrazit více v PubMed

Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L. The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. Sleep medicine reviews. 2019;43:37–46. doi: 10.1016/j.smrv.2018.09.008. PubMed DOI

Postuma RB, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain: a journal of neurology. 2019;142:744–759. doi: 10.1093/brain/awz030. PubMed DOI PMC

Rees RN, Noyce AJ, Schrag A. The prodromes of Parkinson’s disease. Eur J Neurosci. 2019;49:320–327. doi: 10.1111/ejn.14269. PubMed DOI PMC

Berg D, et al. MDS research criteria for prodromal Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society. 2015;30:1600–1611. doi: 10.1002/mds.26431. PubMed DOI

Hogl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update. Nature reviews. Neurology. 2018;14:40–55. doi: 10.1038/nrneurol.2017.157. PubMed DOI

Skorvanek M, et al. Alpha-Synuclein antibody 5G4 identifies manifest and prodromal Parkinson’s disease in colonic mucosa. Movement disorders: official journal of the Movement Disorder Society. 2018;33:1366–1368. doi: 10.1002/mds.27380. PubMed DOI

Doppler K, et al. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease. Acta Neuropathol. 2017;133:535–545. doi: 10.1007/s00401-017-1684-z. PubMed DOI PMC

Iranzo, A. et al. Alpha-Synuclein aggregates in labial salivary glands of idiopathic rapid eye movement sleep behavior disorder. Sleep41, 10.1093/sleep/zsy101 (2018). PubMed

Hlavnicka J, et al. Automated analysis of connected speech reveals early biomarkers of Parkinson’s disease in patients with rapid eye movement sleep behaviour disorder. Sci Rep. 2017;7:12. doi: 10.1038/s41598-017-00047-5. PubMed DOI PMC

Hanuska, J. et al. Eye movements in idiopathic rapid eye movement sleep behaviour disorder: High antisaccade error rate reflects prefrontal cortex dysfunction. Journal of sleep research, e12742, 10.1111/jsr.12742 (2018). PubMed

McDade EM, et al. Subtle gait changes in patients with REM sleep behavior disorder. Movement disorders: official journal of the Movement Disorder Society. 2013;28:1847–1853. doi: 10.1002/mds.25653. PubMed DOI PMC

Bauckneht M, et al. Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis. Sleep medicine reviews. 2018;41:266–274. doi: 10.1016/j.smrv.2018.04.001. PubMed DOI

Fearnley JM, Lees AJ. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain: a journal of neurology. 1991;114(Pt 5):2283–2301. doi: 10.1093/brain/114.5.2283. PubMed DOI

Iranzo A, et al. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder. Annals of neurology. 2017;82:419–428. doi: 10.1002/ana.25026. PubMed DOI

Jennings D, et al. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort. JAMA neurology. 2017;74:933–940. doi: 10.1001/jamaneurol.2017.0985. PubMed DOI PMC

American Academy of Sleep Medicine. International classification of sleep disorders. 3rd edn, (American Academy of Sleep Medicine, 2014).

Frauscher B, et al. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep. 2012;35:835–847. doi: 10.5665/sleep.1886. PubMed DOI PMC

Darcourt J, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. European journal of nuclear medicine and molecular imaging. 2010;37:443–450. doi: 10.1007/s00259-009-1267-x. PubMed DOI

Calvini P, et al. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. European journal of nuclear medicine and molecular imaging. 2007;34:1240–1253. doi: 10.1007/s00259-006-0357-2. PubMed DOI

Sankoh, A. J., Huque, M. F. & Dubey, S. D. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med16, 2529–2542, doi:10.1002/(sici)1097-0258(19971130)16:22<2529::aid-sim692>3.0.co;2-j (1997). PubMed

McCarter SJ, et al. Antidepressants Increase REM Sleep Muscle Tone in Patients with and without REM Sleep Behavior Disorder. Sleep. 2015;38:907–917. doi: 10.5665/sleep.4738. PubMed DOI PMC

Barber, T. R. et al. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder. Sleep40, 10.1093/sleep/zsx071 (2017). PubMed PMC

Postuma RB, Gagnon JF, Vendette M, Montplaisir JY. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson’s disease. Brain: a journal of neurology. 2009;132:3298–3307. doi: 10.1093/brain/awp244. PubMed DOI

Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB. Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain: a journal of neurology. 2017;140:1959–1976. doi: 10.1093/brain/awx118. PubMed DOI

Noyce AJ, et al. Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society. 2018;33:478–482. doi: 10.1002/mds.27282. PubMed DOI

Jennings D, et al. Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology. 2014;83:1739–1746. doi: 10.1212/WNL.0000000000000960. PubMed DOI PMC

Chahine LM, et al. Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder. NPJ Parkinsons Dis. 2019;5:2. doi: 10.1038/s41531-018-0073-1. PubMed DOI PMC

Sharabi Y, Goldstein DS. Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease. Journal of the neurological sciences. 2011;310:123–128. doi: 10.1016/j.jns.2011.06.047. PubMed DOI PMC

Knudsen K, et al. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. The Lancet. Neurology. 2018;17:618–628. doi: 10.1016/S1474-4422(18)30162-5. PubMed DOI

Gibbons CH, Freeman R. Clinical implications of delayed orthostatic hypotension: A 10-year follow-up study. Neurology. 2015;85:1362–1367. doi: 10.1212/WNL.0000000000002030. PubMed DOI PMC

Rahayel S, et al. Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder. Neurology. 2018;90:e1759–e1770. doi: 10.1212/WNL.0000000000005523. PubMed DOI PMC

Bertrand JA, et al. Color discrimination deficits in Parkinson’s disease are related to cognitive impairment and white-matter alterations. Movement disorders: official journal of the Movement Disorder Society. 2012;27:1781–1788. doi: 10.1002/mds.25272. PubMed DOI

de la Fuente-Fernandez R. A predictive model of neurodegeneration in idiopathic REM-sleep behavior disorder. Parkinsonism & related disorders. 2013;19:1009–1012. doi: 10.1016/j.parkreldis.2013.07.003. PubMed DOI

Zoetmulder M, et al. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2016;12:895–903. doi: 10.5664/jcsm.5896. PubMed DOI PMC

Postuma RB, Gagnon JF, Rompre S, Montplaisir JY. Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology. 2010;74:239–244. doi: 10.1212/WNL.0b013e3181ca0166. PubMed DOI PMC

Liu Y, et al. Electromyography activity level in rapid eye movement sleep predicts neurodegenerative diseases in idiopathic rapid eye movement sleep behavior disorder: a 5-year longitudinal study. Sleep medicine. 2019;56:128–134. doi: 10.1016/j.sleep.2019.01.018. PubMed DOI

Valencia Garcia S, et al. Ventromedial medulla inhibitory neuron inactivation induces REM sleep without atonia and REM sleep behavior disorder. Nat Commun. 2018;9:504. doi: 10.1038/s41467-017-02761-0. PubMed DOI PMC

Fereshtehnejad SM, et al. Validation of the MDS research criteria for prodromal Parkinson’s disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort. Movement disorders: official journal of the Movement Disorder Society. 2017;32:865–873. doi: 10.1002/mds.26989. PubMed DOI

Iranzo A, et al. Characterization of patients with longstanding idiopathic REM sleep behavior disorder. Neurology. 2017;89:242–248. doi: 10.1212/WNL.0000000000004121. PubMed DOI

Mahlknecht, P. et al. Caveats of Neurodegenerative Risk Stratification in Idiopathic REM Sleep Behavior Disorder by Use of the MDS Research for Prodromal Parkinson’s Disease. Sleep40, 10.1093/sleep/zsx131 (2017). PubMed

Postuma RB, et al. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep. 2013;36:1579–1585. doi: 10.5665/sleep.3102. PubMed DOI PMC

Yuan TF, Slotnick BM. Roles of olfactory system dysfunction in depression. Progress in neuro-psychopharmacology & biological psychiatry. 2014;54:26–30. doi: 10.1016/j.pnpbp.2014.05.013. PubMed DOI

Analysis of striatal connectivity corresponding to striosomes and matrix in de novo Parkinson's disease and isolated REM behavior disorder

Whole brain pattern of iron accumulation in REM sleep behavior disorder

Magnetic susceptibility changes in the brainstem reflect REM sleep without atonia severity in isolated REM sleep behavior disorder

Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson's disease

Articulatory undershoot of vowels in isolated REM sleep behavior disorder and early Parkinson's disease

Automated video-based assessment of facial bradykinesia in de-novo Parkinson's disease

Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder

Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder